MedTrace Logo

Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds

NCT01434914 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2014-05-13

No results posted yet for this study

Summary

This is a randomized, double-blind, placebo-controlled trial with octenisept® or placebo in patients with chronic leg ulcers. The study will be conducted at a single center with a total of 70 patients. Patients will be randomized to either the octenisept® group or to the placebo group.

Conditions

  • Ulcus Cruris

Interventions

DRUG

octenisept®

Cutaneous solution

DRUG

Placebo

Cutaneous use

Sponsors & Collaborators

  • Schülke & Mayr GmbH

    lead INDUSTRY

Principal Investigators

  • Matthias Augustin, MD · Universitätsklinikum Hamburg-Eppendorf

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01434914 on ClinicalTrials.gov